Department of Veterans Affairs

Myriad collaborates with Department of Veterans Affairs

Tuesday, November 14, 2017

Assurex Health, a wholly-owned subsidiary of Myriad Genetics, announced that the Department of Veterans Affairs (VA) recently initiated a national, multicenter trial to evaluate the company’s GeneSight test to help improve health outcomes for veterans diagnosed with major depressive disorder (MDD). Approximately 20% of the 2.6 million veterans who deployed to Iraq or Afghanistan returned with MDD or a related mental health condition, and tragically suicide rates for veterans are twice that of the U.S. population.

[Read More]

Shirley Ryan AbilityLab launches to move scientific research from bench to bedside

Monday, April 17, 2017

The Rehabilitation Institute of Chicago (RIC) has moved into a new research hospital facility and renamed itself the Shirley Ryan AbilityLab. The former RIC now occupies a $550 million, 1.2 million square foot facility located on prime real estate in downtown Chicago. The AbilityLab aims to create a setting in which research scientists, engineers and other specialists can work side-by-side with clinicians and patients to improve treatment. This approach is a departure from traditional methods of organizing clinical practice and research, and will serve as an experimental model for medical institutions to observe.

[Read More]

VA, Prostate Cancer Foundation partner to expand clinical research

Thursday, December 1, 2016

The Department of Veterans Affairs (VA) has announced an important and substantial partnership with the Prostate Cancer Foundation (PCF) to prevent, screen and promote research to speed the development of treatments and cures for prostate cancer among Veterans. Announcement of the partnership was made during Launch Pad: Pathways to Cancer InnoVAtion, a joint VA/PCF summit that brings together world-class oncology experts, corporate and nonprofit partners to discuss research, big data, technology and clinical solutions to advance screening, diagnostics and care coordination for cancer and to promote the implementation of best practices across the VA healthcare system. 

[Read More]

Cohen Veterans Bioscience, Stanford University partner on PTSD

Wednesday, October 19, 2016

Despite many years of pioneering work characterizing the brains, behavior, and physiology of individuals with post-traumatic stress disorder (PTSD), the field of psychiatry lacks objective biological measures for understanding the many biological variations in people with the same clinical diagnosis of PTSD. This means that there are no reliable ways to determine who will benefit from which treatment. A new collaboration between Cohen Veterans Bioscience and Stanford University School of Medicine seeks to change this by studying clinical biomarkers as a way to help match patients to the best available treatment.

[Read More]

SCRS, NAVREF partner

Wednesday, September 14, 2016

The Society for Clinical Research Sites (SCRS) and the National Association of Veterans’ Research and Education Foundations (NAVREF) have announced an alliance between the two organizations. This relationship will provide SCRS membership, mentoring and training, and other elements to NAVRAF members. NAVREF is the nonprofit research and education association with 80 member sites affiliated with Department of Veterans Affairs medical centers.

[Read More]

NIH awards $55M to build million-person precision medicine study

Thursday, July 7, 2016

The NIH has announced $55 million in awards in fiscal year 2016 to build the foundational partnerships and infrastructure needed to launch the Cohort Program of President Obama’s Precision Medicine Initiative (PMI). The PMI Cohort Program is a landmark longitudinal research effort that aims to engage 1 million or more U.S. participants to improve our ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.

[Read More]